The functional interplay between the t (9; 22)-associated fusion proteins BCR/ABL and ABL/BCR in Philadelphia chromosome-positive acute lymphatic leukemia

A Rafiei, AA Mian, C Doering, A Metodieva… - PLoS …, 2015 - journals.plos.org
The hallmark of Philadelphia chromosome positive (Ph+) leukemia is the BCR/ABL kinase,
which is successfully targeted by selective ATP competitors. However, inhibition of BCR/ABL …

Frequencies of BCR:: ABL1 Transcripts in Patients with Chronic Myeloid Leukemia: A Meta-Analysis

P Romero-Morelos, AL González-Yebra… - Genes, 2024 - mdpi.com
Chronic myeloid leukemia (CML) is associated with the Philadelphia chromosome and
distinct BCR:: ABL1 gene transcripts. We assessed the frequencies of these transcripts in …

Distribution of BCR:: ABL1 Transcripts in the Different Clinical Phases of Chronic Myeloid Leukemia: Effect on Hematological Parameters and Patient Survival

P Romero-Morelos, AL González-Yebra… - Genes, 2024 - mdpi.com
Chronic myeloid leukemia (CML) is a hematopoietic stem cell disorder characterized by the
presence of the Philadelphia chromosome, a product of the reciprocal translocation t (9; …

Masked Philadelphia chromosome due to atypical BCR/ABL localization on the 9q34 band and duplication of the der (9) in a case of chronic myelogenous leukemia

G Fugazza, A Garuti, S Marchelli, M Miglino… - Cancer genetics and …, 2005 - Elsevier
The cytogenetic studies and molecular evaluation of a Philadelphia chromosome negative
chronic myelogenous leukemia patient with trisomy 21 (100% metaphases) and trisomy 9 …

Comparison of mutated ABL1 and JAK2 as oncogenes and drug targets in myeloproliferative disorders

C Walz, NCP Cross, RA Van Etten, A Reiter - Leukemia, 2008 - nature.com
Constitutively activated mutants of the non-receptor tyrosine kinases (TK) ABL1 (Abelson
murine leukemia viral (v-abl) homolog (1) protein) and JAK2 (JAnus Kinase 2 or Just …

Chronic myeloid leukemia

T Fioretos - … and Molecular Genetic Aberrations of Tumor Cells, 2015 - Wiley Online Library
Chronic myeloid leukemia (CML) is a clonal bone marrow (BM) disease characterized by
neoplastic overproduction of, mainly, granulocytes. The treatment of CML has changed …

Myelodysplastic syndromes, chronic myeloproliferative diseases, and myelodysplastic/myeloproliferative diseases

JW Vardiman - Seminars in diagnostic pathology, 2003 - Elsevier
This article reviews the major diagnostic criteria for the myelodysplastic syndromes, chronic
myeloproliferative diseases, and myelodysplastic/myeloproliferative diseases. Perhaps the …

Impact of chromosomal rearrangement upon DNA methylation patterns in leukemia

HM Byun, S Eshaghian, D Douer, J Trent… - Open …, 2017 - degruyter.com
Genomic instability, including genetic mutations and chromosomal rearrangements, can
lead to cancer development. Aberrant DNA methylation occurs commonly in cancer cells …

[HTML][HTML] 1, 3-Butadiene metabolite 1, 2, 3, 4 diepoxybutane induces DNA adducts and micronuclei but not t (9; 22) translocations in human cells

VE Walker, A Degner, EW Carter, JA Nicklas… - Chemico-biological …, 2019 - Elsevier
Abstract Epidemiological studies of 1, 3-butadiene (BD) exposures have reported a possible
association with chronic myelogenous leukemia (CML), which is defined by the presence of …

[PDF][PDF] A mathematical model of BCR-ABL autophosphorylation, signaling through the CRKL pathway, and gleevec dynamics in chronic myeloid leukemia

P Charusanti, X Hu, L Chen, D Neuhauser… - Discrete and Continuous …, 2004 - Citeseer
A mathematical model is presented that describes several signaling events that occur in
cells from patients with chronic myeloid leukemia, ie autophosphorylation of the Bcr-Abl …